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Résumé
Le rôle physiologique et l’importance clinique des neurones dopaminergiques
mésencéphaliques (MesDA) sont bien connus dans des maladies telles que la
schizophrénie, les comportements de dépendance et, de façon plus importante, chez
les personnes atteintes de la maladie de Parkinson (PD). Les neurones MesDA sont
localisés dans la partie ventrale du mésencéphale et forment la substantia nigra (SN)
et le ventral tegmental area (VTA). L’expression du facteur de transcription à boîte
homéo Pitx3 dans le cerveau est restreinte aux neurones MesDA et son expression
est maintenue au cours de la vie adulte chez les rongeurs et les humains. Fitx3 est
aussi retrouvé hors du système nerveux, comme dans l’oeil par exemple, où il est
exprimé dans le cristallin en développement. Le développement anormal du cristallin
a été observé chez la souris aphalda (ak), dans laquelle une mutation est survenue
naturellement. Cette mutation, récemment identifiée, est causée par deux délétions
dans le gène Fitx3, incluant une mutation qui délète l’exonl. La présente étude
montre qu’un seul sous-groupe des neurones MesDA exprime Pitx3 et que, dans la
souris aphakia déficiente en Pitx3 dans le cerveau, ce sous-groupe disparaît
progressivement par apoptose durant le développement fétal (SN) et post-natal
(VTA). Ceci résulte en un niveau très bas de dopamine dans le striatum et une
akinésie. Similairement à la forme humaine de la maladie de Parkinson, les neurones
dorsaux de la SN (négatifs pour Pitx3) sont épargnés chez la souris mutante. Ainsi,
Pitx3 définit une voie de survie pour les neurones impliqués dans la maladie de
Parkinson et qui sont requis pour l’activité locomotrice spontanée.
Mots clés: boîte homéo, facteur de transcription, Fitx3, mésencéphale, dopamine,
souris aphakia, maladie de Parkinson.
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Abstract
The physiological role and clinical relevance of mesencephalic dopaminergic
(MesDA) neurons are well recognized in schizophrenia, addictive behavioural
disorders and, most importantly, Parkinson’s disease (PD). MesDA neurons are
located in the ventral midbrain to form the substantia nigra (SN) and ventral
tegmental area (VTA). Expression of the homeobox transcription factor Pitx3 is, at
the brain level, confined to MesDA neurons and its expression is maintained
throughout aduit life in both rodents and humans. Extraneural Fitx3 expression was
shown in the eye, where it is present in the developing lens. Abnormal eye lens
development was observed in the naturally occurring aphakia (ak) mouse mutant,
which was recently found due to two 5’ deletions in the Fitx3 gene, including one
that deletes exoni. Here, it is shown that only a subset of MesDA neurons express
Fitx3 and that in aphakia mice, which are Pitx3-deficient at the brain level, this
subset is progressively lost by apoptosis during fetal (SN) and post-natal (VTA)
development, resulting in very low striatal DA and akinesia. Similar to human PD,
dorsal $N neurons (Pitx3-negative) are spared in mutant mice. Thus, Pitx3 defines a
pathway for survival of neurons that are implicated in PD and that are required for
spontaneous locomotor activity.
Key words: Homeobox, transcription factor, Pitx3, midbrain, dopamine, aphakia
mouse, Parkinson’s disease
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I. INTRODUCTION
1. Generat introduction
The complexity of the mammalian brain depends for a great part on the
diversity of differentiation and maturation pathways taken by neuronal ceils. Several
genes are known to define large domains of the central nervous system (CNS)
during early development, acting on mitotic precursors. These genes pattem the
neuroepithelium and speciii the identity of neuronal precursors along the anterior
posterior (A-P) and dorso-ventral (D-V) axes [J]. Final differentiation occurs once
precursors have exited the ceil cycle and is characterized by expression of the
enzymes or neurotransmitters required for neural function. Besicles, many
developing neural systems undergo a period of natural celi death, which determines
the number of neurons that survive into maturity [2]. Few genes have been
implicated in these late events of differentiation and maturation of specific neuronal
populations.
2. Mesencephatic dopaminergic (MesDA) systent
The catecholamine dopamine (DA) is an important regulator of many neuraf
functions including motor regulation, neuroendocrine hormone release, cognition,
emotive behaviour and reward [3]. Tyrosine hydroxylase (TH) catalyses the rate
limiting step for DA synthesis, hydroxylating tyrosine to 3,4-
dihydroxyphenylalanine (L-DOPA), which is subsequently converted to DA by the
2more abundantly expressed L-DOPA-decarboxylase (LDDC) or amino acid
decarboxylase (AADC). Although these biosynthetic enzymes are present in ail parts
of DA neurons, the neurotransmitter is predominantly synthesized in the nerve
terminais [4]. Upon release from the presynaptic terminal into the synaptic clefi, DA
neurotransmission is terminated by reuptake into the presynaptic DA fibres by the
DA membrane transporter (DAT), which is unique to DA fleurons.
In mammals DA neurons are relatively few, when compared to the total
number of brain fleurons. They are mainly located in the ventral
midbrainlmesencephalon to form the substantia nigra (SN) and the ventral tegmental
area (VTA) [5]. The SN is composed of the dorsally situated pars compacta (SNc),
that exhibits intense dopamine fluorescence [6], and the ventrally situated pars
reticulata ($Nr), that contains hardly any dopamine fluorescence but the
neurotransmitter gamma-aminobutyric acid (GABA) instead [7]. In rodents, DA
neurons arising from the SNc project to the striatum (corresponding to the caudate
putamen in primates) and receive innervation from multiple structures in the
diencephalons and telencephalon. The ascending nigrostriatal pathway regulates
motor control [4] and its degeneration in humans is associated with Parkinson’s
disease (PD) [8]. DA neurons from the VTA project to the limbic system and cortex,
and are invoÏved in emotional and reward behaviour and motivation [3].
Disturbances in the mesencephalic dopaminergic (MesDA) system have been
associated with schizophrenia, addictive behavioural disorders and attention-deficit
hyperactivity disorder (ADRI)) [9, 10]. Since the physiological role and clinical
relevance of DA neurons are well recognized, the mechanisms underlying their
development have been the obj ect of intense investigation.
32.1 Early MesDA neuron development
At embryonic day 11.5 tEl 1.5) of mouse development, the first 1H-
expressing neurons arise at the most ventral rim of the neuroepithelium lining up
along the mesencephalic flexure of the ventral midbrain [11]. hie precise
anatomical locaÏization and ffinctional differentiation of DA neurons in the
mammalian brain is achieved through the action and gradient disposition of various
diffusible factors. Data from tissue transplantation and expiant culture studies and
biochemical and genetic experiments have demonstrated that DA neurons develop at
sites where the signais of two distinct signalling molecules, sonic hedgehog (Shh)
and fibroblast growth factor 8 (FgfB), both necessary and sufficient for the induction
of DA neurons, intersect [12]. These inductive molecules are thought to activate
cascades of other signalling moiecules and transcription factors, which lead to the
final differentiation and maturation of DA neurons. Before the expression of DA
specific markers, (ventral) midbrain markers are present in these cells. Among the
earliest markers of the region are Otx2, Gbx2, Wnt], Lmx]b, En], En2, Fax2 and
Fax5. The first specific signs of the birth of MesDA neurons shortly follow the
induction of the orphan nuclear hormone receptor Nurri (E1O.5) [13] and the
homeobox gene Fitx3 tEl 1) [14], when expression of the key enzyme in DA
synthesis TH is initiated and completed.
MesDA neurons are generated from proliferating ceils facing the ventricle,
migrate ventrally from the ventricular surface, and then laterally along the ventral
pial surface to form the VIA and SNc t15]. Their generation in mammals occurs
4according to a strict neurogenetic timetable that is Ïinked to the neurogenetic
gradients in the striatum [16]. Quantitative analysis of neuronal birth dates using
pulse labelling with single injections of 3H thymidine injections throughout mouse
embryogenesis indicates that the neurons ofboth SN and VIA are generated on days
E1O-E14; most SN neurons are generated on days Fil and E12, most VIA neurons
are generated on days E12 and E13 [17]. By E16, the distribution of TH neurons is
basically similar to that seen in aduit mice, in which the VIA and SNc are clearly
distinguishable [15].
2.2 Late MesDA neuron development
During the course of development, most neuronal populations undergo a
regressive event, termed natural, developmental, or physiological ceil death [2]. This
process eliminates more than haif of the neurons initially present and seems to be
highly regulated, ofien by the trophic support that neurons receive from their
postsynaptic targets [18] as well as from afferent projections [19]. It has been
postulated that the process of developmental celi death serves critical purposes,
including the creation of appropriate relationships between the number of neurons
and the size of the target so as to foster a structural harmony crucial to establishing a
functional brain neurotransmission network [20].
MesDA neurons seem not to escape this scuipting process. Jndeed, during
rodent development, a large number of SNc and VTA neurons die by apoptosis [21,
22]. This process is essentially a postnatal event. In mice, the highest number of
apoptotic neurons is seen at postnatal day 2 (P2) followed by a steep drop until P10.
5Thereafter, the number of apoptotic neurons transiently increases, reaches a peak at
P14 and drops again. By P32 and on into adulthood, apoptotic neurons are no longer
seen [22]. Similar findings have been described in rat t21, 23].
Despite the occurrence of developmental apoptosis, however, there is no
decrease in TH neurons numbers in $Nc and VIA but, on the contrary, a
progressive increase; the proportion of ‘TH immunostainable’ neurons relative to the
total number of neurons present increases over time and parallels the increase in 1H
neuron numbers [22]. A substantial part of the MesDA fleurons, which are ail
generated on days E1O-E14, will thus flot express 1H until the first postnatal weeks
Together with the finding that TH expression and dopamine levels do not reaci aduit
levels before 4-6 weeks of age [24], this suggests that there is a process of
‘phenotypic maturation’ ofMesDA fleurons that extends into young adulthood.
2.3 Genes in MesDA neuron development
2.3.1 Early genes
2.3.1.1 A-P patternïng genes
Compiexity within the CNS is generated in a stepwise manner. The
formation of the mesencephalon (midbrain) and metencephalon (embryological
precursor to aduit anterior hindbrain structures including the cerebellum) is one of
the best studied examples of sequential pattem formation. The initial A-P
regionalization begins during gastrulation and is characterized by the broad
induction of several genes in the anterior plate [25]. The presumptive fore-midbrain
and the prospective rostral hindbrain are visualized at E7.75 of mouse development
6by the expression of two transcription factors, Otx2 and Gbx2 respectively t26].
Their expression domains meet and are mutually exclusive at the future
midbrain1hindbrain boundary (IVIIIB) [27]. Gain-of-function studies have
demonstrated that mutual antagonism between Otx2 and Gbx2 determines the
position of the MHB [2$]. Otx2 knockout mice lack the forebrain, midbrain and
rostral hindbrain [29-3 1], Gbx2 knockout mice show abnormalities in the isthmus
structure and caudal extension of the midbrain [32].
The second phase of A-P pattem formation begins when an organizer is
established just caudal to the Otx2/Gbx2 junction, the isthmic organizer (IsO), that
develops in conjunction with the isthmus. Transplantation and expiant studies have
demonstrated that the IsO is responsible for patteming much of the midbrain and
hindbrain along the rostrocaudal axis [33]. The proper establishment of the IsO is
not just defined by the two transcription factors Otx2 and Gbx2 but rather by a
complex cascade of genetic interactions. Soon afier Otx2 and Gbx2, the signalling
molecule Wntl (encoded by a vertebrate homologue of the Drosophila wingless
gene), Fgf3 and the homeobox transcription factor Eni (encoded by a vertebrate
homologue of the Drosophila segmentation engrailed gene) are activated in broad
areas along the posterior midbrain and rostral hindbrain. Then their expression
becomes more restricted and between E9 and ElO, the restricted expression ofthese
genes defines an isthmic molecular code: Otx2 and Wnt] identify the midbrain side
of the MHB, FgJ2 and Gbx2 identify the hindbrain side and En] identifies both sides
[34]. Mutant mice that are homozygous nuli for Wntl fail to form a normal MHB
and, ultimately, lack most of the midbrain, the isthmic nuclei and the anterior
cerebellum t35-40]. Partial loss-of-function mutations in FgJ8 disrupt midbrain and
7cerebellum development in mouse and fish [41, 42]. En]-mutants lack the
cerebellum and inferior colliculus [43], a phenotype similar to, but milder than, that
of Wntl nuil mutants. The midbrain- and cerebellum-inducing properties of the IsO
have so far only been demonstrated for Fgf [44, 45]; when implanted in the caudal
diencephalon, fgf8-soaked beads can induce an ectopic midbrain by modifying the
fate ofthe host tissue surrounding the beads.
In addition to the genetic cascade mentioned above, expression smdies from
the past years have identified other early genes that get (transiently) expressed in the
MHB of the developing embryo. Pax2, Pax5, Lmxlb and En2 are expressed in
overlapping bands of celis in the presumptive mid- and hindbrain and analyses of
their gene mutants have provided an essential resource for further explonng the
cellular events that control midbrain formation. The paired-box-containing
transcription factor Pax2 (encoded by a vertebrate homologue of the Drosophila
paired gene) is expressed between E7.5 and El 1 and targeted inactivation resuits in
exencephaly at the midbrain region [46]. PaxS shortly follows Fax2 (E8.25) and
reaches its maximal expression at E12.5 [47, 48]. The brain phenotype of
homozygous PaxS mutant mice manifests as a change in the foliation pattern on the
anterior cerebellum and as a reduction of the infenor colliculi near the midline that
are first visible only at E16.5 [49, 50]. Interestingly, analysis ofPax2/5 compound
mutant embryos show a loss of midbrainlhindbrain anlagen and Fgf8/Wntl/Enl
expression, and a subsequent complete loss ofthe midbrain and cerebellum, together
with fusion of the fore- and hindbrain [51]. The LIM homeobox gene Lmx]b is
expressed at E7.5 in the future IvllIB region. Early developmental expression
extends anterior into the ventral hypothalamic area and the ventral midbrain, and
$posterior into the dorsal hindbrain and the dorsal part of the spinal cord [52]. Its
expression continues into adulthood in MesDA neurons. In Lmx]b mutant mice, a
small set of TH neurons develops in the ventral midbrain, but subsequently gets lost;
afier E16 no 1H neurons are present in this region [52]. In addition, severe deficits
were observed in other regions ofthe midbrain [52]. En2 is expressed at E$.5, halfa
day later than En], and has a similar expression profile to En] [53]. En2 mutants
show reduction in the size of the cerebellum and an abnormal cerebellar foliation
pattem [54, 55]. Recently, it was shown that MesDA neurons express both engrailed
proteins into adulthood [56]. The proteins are able to compensate for each other in
the development of MesDA neurons and targeted deletion of both Eit] and En2
genes resuits in complete loss ofTH neurons by E14 [56].
2.3.1.2 D-V patterning genes
As stated before, the generation of a proper functional MesDA system
requires a developmental programme that ensures that appropriate cell types are
generated at the correct time, in specific positions and in the correct numbers. The
first major insight into the understanding of these processes came with the discovery
of Shh. Shh is produced by two ventral midline signalling centres: the notochord, the
axial mesoderm that underlies the ventral neural plate; and the floor plate, a
specialized population of celis at the ventral midiine of the CNS [57].
Transplantation and explant studies had already demonstrated that these two
signalling centres were responsible for ventralizing the neural tube [58], and Shh
was shown to be present in these, precisely at the times when the centres were
9known to have inducing capacities [57]. Subsequently, gain- and loss-of-function
experiments demonstrated that Shh is both necessary and sufficient to induce
ventral-neural-ceil types [59, 60]. Shh was postulated and shown to function in a
concentration-dependent way as a gradient morphogen, acting both directly and at
long-range to pattern the ventral neural tube [61]. Signalling by a Shh gradient
establishes distinct progenitor domains by regulating the expression of a set of
homeobox transcription factors that comprises, at the spinal cord level, members of
the Pax, Nkx, Dbx and Irx families [62-64]. These homeobox transcription factors
have been subdivided into class I and class II proteins, based on their differential
regulation by Shh signalling. Class I proteins are synthesized by neural progenitor
celis in the absence of Shh, whereas production of class II proteins depends upon
exposure to Shh [62-66]. By the induction or the repression of the levels of these
transcription factors, Shh defines five progenitor domains in the ventral neural tube.
In tum, the pairs of transcription factors that abut a common progenitor-domain
boundary repress each other’ s expression, contributing to the definition of the neural
progenitor domains and the positions at which postmitotic neurons are generated
[67, 68]. It is possible that similar mechanisms are responsible for determining
ventral ceil fate in more anterior areas of the CNS. Recently, Shh-mediated
induction of similar molecularly distinguished territories was described for the
developing chick midbrain [69]. At E5, five midbrain territories can be identified:
arc 1 (marked by PhoxA-expressing motomeurons), arc 2 (Gata2- and Foxa2-
expressing neurons), a Pax6-expressing stripe, arc 3 (Gata2-expressing but Foxa2-
negative neurons) and an Evxl stripe [69]. It remains to be determined how these
territories influence MesDA neuron development, but Shh has been clearly shown to
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mediate their induction [121: DA neurons develop at sites where the signais of the
two molecules Shh and Fgf intersect. Besides, these two extracellular inducers are
necessary and sufficient for the induction of DA neurons in multiple locations in the
neural tube [12].
Recently, it was postuiated that Fgf signailing, whose patteming activity
along the A-P axis has been extensively studied, has also a role in D-V patteming of
the MHI3: the expression of Shh target genes was shown to be suppressed in a dose
dependent manner by a dominant-negative Fgf receptor [70], suggesting that
apparently functional Fgf signalling is necessary for proper D-V pallerning at the
MHB.
2.3.2 Late genes
2.3.2.1 Nurri
Nurr] is a member of the orphan nuclear hormone receptor superfamily of
transcription factors and is highly homologous to its other members Nur77, also
caÏled NGfI-B (nerve growth factor inducible-factor B) and Non [71]. Nurni
expression appears to be predominantly brain-specific, whereas Nur77 and Non] are
found in many tissues [71]. fr the adult rodent brain, the three genes are expressed in
severaÏ unrelated regions of the CNS, in both distinct and overlapping pattems [72-
74]. The most striking regional difference is the presence of Nurri, but absence of
Nur77 and Non, in the SN and VTA.
In the embryonic midbrain, Nurr] expression covers the entire ventral
region. Only a small proportion of the Nurrl-expressing neurons overlaps with the
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MesDA progenitor ceils. Thus, its midbrain expression is not uniquely linked to
MesDA neurons. Nurri expression is confined to postmitotic progenitor celis and
starts at E 10.5 in the mouse, just before the induction of the dopaminergic markers
Pitx3 (Eh) and TH (E11.5) t13, 14, 75, 76]. The expression is maintained in the
aduit stage, albeit in a more limited pattem, but including the MesDA system [72,
73, 77].
The function of Nurri has been addressed by the creation of nuli-mutant
mice. Nurri knockout mice develop until gestation but die soon after birth.
Although the cause of death is flot entirely clear, it appears to involve inabiiity to
suckie. Mutant mice display movement disturbances including severe difficulties in
tuming when placed on their backs and abnormal flexion-extension movements of
the limbs [75]. Analysis of the brain of these animais showed that in newbom
animais, no TH or AADC couid be detected in the midbrain and no DA was detected
at the level of the striatum [75, 78, 79]. The Nurri-!- phenotype is remarkably
midbrain-specific since hypothalamic dopaminergic neurons and neural crest
derived 1H ceils in the adrenal medulla, that both express Nurri, are flot affected by
the ablation ofNurrl [78, 80, 81]. Possibly, these latter two ceil populations remain
unaffected due to their concomitant expression ofNur77 and Non [72-74].
Aithough it was initiaily concÏuded that the absence of Nurri causes
“agenesis” of MesDA neurons [75], several additional studies demonstrated a more
refined role of Nurri in MesDA neurons. Midbrain progenitor cells in E 12.5 Nurri
nuhl mutants fail to induce TH, but express other MesDA markers like Enl/2, Lmx]b
and Fitx3 [52, 76, 7$]. Thus, it appears that the MesDA progenitor celis are initiaiiy
generated and that the oniy marker that is missing is TH.
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The perinatal survival of these Nurri-!- MesDA progenitor celis is flot
entirely clear, since conflicting findings exist. Some studies showed increased
apoptosis and decreased neuron numbers in the ventral midbrains of Nurri mutant
newboms [76, 78, 80], whereas others reported comparable number of apoptotic
celis and no changes in ceil number in the SN and VTA of wildtype mice and Nurri
mutants [82]. Another conflicting finding in Nurri mutants is whether the MesDA
progenitor cells migrate to their normal positions and extend projections toward the
striatum. Wallén et al. [76] showed at E15.5 a marked reduction and mainly medial
localization of MesDA markers, suggesting that the celis are unable to migrate
laterally. In newboms, they showed no retrograde fluorogold tracer labeling in the
ventral midbrain afler striatal injection, suggesting that the too medially located
MesDA progenitor celis were unable to innervate the striatum. Witta et al. [82],
however, reported no apparent difference in topographic pattem of SN and VTA
neurons in Nurri mutant newboms and normal anterograde Dii tracer-labeling in the
striatum afier midbrain injection, suggesting that the nigrostriatal neuronal
connections are well developed, even in the absence of DA. The reason for these
discrepancies is unknown and could resuit from different genetic background of the
Nurri knockout mouse strains or differences in how the gene targeting ofNurr] was
achieved.
In a recent tissue culture study from Tômqvist et al. [$3], TH neurons were
found in dissected ventral mesencephalon from both E10.5 and E15.5 Nurri mutants
when cultured in the presence of senim medium. A similar finding was reported by
Eells et al. [$4], who detected TH neurons in dissociated ventral midbrain neurons
from newbom Nurri mutants that were grown on an astrocyte feeder layer. These
13
resuits strongÏy suggest that Nurri is not absolutely required for TH expression in
ventral midbrain in vitro. Stili, Nurri has been shown to activate transcription of the
TH gene promoter [85-87], although others reported no effect on TH promoter
activity [88]. Besides, Nurri has been reported to regulate DAT transcription [89].
R5mqvist et al. [83] aiso reported a clear difference in nerve fiber distribution in
wildtype and Nurri mutant cultures when co-cultured with striatal tissue. No well
defined nerve fiber bundies were found in knockout cultures suggesting that DA
axon pathfinding does require Nurri. It was noted, however, that these fmdings were
derived from the same une of Nurri knockout animais previously shown to iack
nigrostriatai connections [76].
The relevance of the human homologue of the murine Nurri gene, aiso
known as the NR4A2 or NOT gene [71]; [90] to the pathogenesis of diseases that
affect the MesDA system has been addressed recently by severai groups. Buervenich
et ai. [91] reported two different missense mutations in the third exon ofthe NURRJ
gene in two schizophrenic patients and another missense mutation in the same exon
in an individuai with manic-depressive disorder. Ail three mutations caused a similar
30-40% reduction of in vitro Nurri franscriptionai activity. Chen et ai. [92]
identified a rare variant of the NURRJ gene, with a nucleotide-deletion in the
untransiated exon 1, in two out of one hundred and seventy-seven unreiated Han
Chinese schizophrenic patients from Taiwan. Bannon et al. [93] reported a
significant, more than 50%, reduction in Nurri and DAT mRNA in postmortem
MesDA neurons of cocaine abusers whereas the mRNA level of human vesicular
monoamine transporter 2, a distinct transporter protein expressed in high abundance
within MesDA neurons that mediates the intracellular storage of dopamine [94] but
14
is not known to be regulated by Nurri, was unaltered. Xu et al. [95] found a
significant correlation between homozygozity for the 704$G7049 polymorphism in
intron 6 of the NURRJ gene, that inserts a single nucleotide between nucleotide
positions 704$ and 7049, and PD.
Taken together, it seems that Nurri is an essential factor in the differentiation
program of MesDA progenitor celis and aÏso fulfilis a role in maintaining MesDA
neuron phenotype within the mature CNS, by controlling TH and DAT expression in
a direct or indirect way. It remains to be determined whether the absence of Nurri
causes severe loss of MesDA neurons. Possibly, the Nurr]-/- MesDA progenitor
ceils cannot form or maintain the connections to their targets. The absence of TH
alone is not sufficient for the absence of projections, since TH mutant mice stiil form
projections to the striatum [96]. Altematively, Nurri may function parallel in a
switch from proliferating stem ceils to non-proliferating differentiating celis and be
more fundamental in the control of the celi cycle; Nurri expression starts at about
the same time as neuronal differentiation becomes evident t76] and Nurri can
induce celi cycle arrest and a highly differentiated ceil morphology in the DA
synthesizing ceil line MN9D [97].
2.3.2.2 Pitx3
2.3.3.2.1 The Pitx family
Pitx 1, Pitx2 and Pitx3 are members of a paired family of homeodomain (HD)
transcription factors [14, 98, 99]. RD transcription factor genes encode HD
containing proteins, which play a key role in coordination of gene activity and
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determination of ceil fate in the development of organisms as diverse as yeast,
plants, insects and mammals. The HD proteins share remarkable evoiutionary
conservation ofboth protein structure and function.
The first member of this paired famiiy, Pitxl (pituitary homeobox 1) was
isolated as a transcription factor involved in pro-opiomelanocortin gene transcription
in anterior pituitary corticotropes [99]. The gene is expressed in ceil unes
representing the five anterior pituitary neuroendocrine ceil lineages [100]. Its
expression defines the stomodeum and continues within stomodeai derivates,
including the nasal pit and Rathke’s pouch, the precursor to the anterior and
intermediate lobes of the pituitary gland [101, 102]. Pitx] is also expressed in the
first branchial arch and, more caudauly, in the posterior laterai plate [102], where it
was shown to be implicated in specification ofhindlimb identity [103].
The second family member Pitx2 is another eariy marker for the incipient
Rathke’s pouch and is expressed in ail anterior pituitary neuroendocrine celi lineages
except for the corticotrope lineage [100, 101]. It gets expressed in many tissues
during development, including the ieft lateral plate mesoderm, derivates of the first
branchial arch, the eye, brain, mandible, heart and limbs [101, 104-107]. During
brain deveiopment, early Fitx2 expression paffems within the prosencephalon and
mesencephalon are consistent with the prosomeric model of fore- and midbrain
development [104, 106, 108]. Subsequently, Pitx2 expression becomes iimited to
discrete brain nuclei like the subthalamic nucleus (STN) and the zona incerta pars
dorsalis of the thalamus [104, 106]. Recent studies on viscerai organogenesis
reported that manipulation of Fitx2 expression is sufficient to reprogram the
left/right body asymmetry in vertebrates and Fitx2 appears to be the most
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downstream gene in this Iaterality pathway that includes Shh, activinflB, nodal and
lefty-2 [109, 110].
Pitx3 is expressed from Bi 1 in mouse mesencephalic progenitor celis and
double-staining with 1H probes showed that Pitx3 expression completely overlapped
with TH-positive celis, demonstrating that Fitx3 is expressed in MesDA neurons
[14]. This is the only site of Fitx3 expression in the CNS and its expression is
maintained throughout aduit life in mice, rats and humans. Extraneural Pitx3
expression was shown in the developing lens, nosecartilage, tongue, condensing
mesenchyme around the sternum and vertebrae and in the head muscles [14, iii,
112].
2.3.3.2.2 Pitx3 in eye development
Mutations in the human homologue of Pitx2, RIEGJ, play a well-known role
in the Rieger syndrome (abnormalities of the anterior chamber of the eye, dental
hypoplasia, craniofacial dysmorphism and umbilical abnormalities) and iris
hypoplasia [105, 113]. Based on this role ofFitx2 and the expression ofFitx3 during
lens development, Fitx3 was suggested to be a strong candidate gene for eye
disorders. Besides, Pitx3 was mapped to the region ofthe aphalda (ak) mutation on
mouse chromosome 19 [112]. Ak is a recessive mutation, described originally by
Varnum and Stevens in 1968, that spontaneously occurred in the l29/Sv-Sl’ strain
[114]. The ak mutation causes blindness due to microphthalmia with an absence of
lens, iris and pupil. Retinal folds partially fili the vitreous chamber, lacrimal glands
are enlarged and eyelids are closed in the aduit. These anomalies are caused by an
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arrest of lens development at the stage of the lens vesicle formation around El 0.5-
Eh [114, 115]. In the aWak mutants, there is persistence ofthe Yens stalk at E12.5
interrupting the comeal mesenchyme and leading to a permanent close contact
between the developing comea and other ocular tissues without the formation of an
anterior chamber [1 15, 116]. No other systemic abnormalities were reported in these
mice. Recently, the Fitx3 gene was shown zero recombination with the ak mutation
and screening of the gene for mutations revealed a 652 basepair (bp) deletion in the
5’ flanking region approximately 2500 bp from the transcription startsite and a 1423
bp deletion eliminating putative promoter sequences, the noncoding exon 1 and part
ofintron 1 [117, 118]. The levels ofFitx3 transcripts are only about 5% ofwildtype
levels in aWak mice. These data strongly suggest that the ocular ak phenotype is
caused by a dramatic reduction in Fitx3 expression as a resuit of a double deletion in
the gene. The relative contribution of the two deletions to the phenotype remains to
be detennined. The minor deletion contains sequences with some similarity to
transcription binding sites and a large polymorphic GAA repeat [117, 118]. This
repeat is approximately 150 bp larger in wildtype DBA and C57 mouse substrains
than in the various wildtype 129 substrains and others tested [118], suggesting that
large changes in this area do not affect eye development. The major deletion extends
from the putative promoter into the first intron. Nonetheless, a low level of Pitx3
transcripts is detectable. This means that a weak promoter activity must be present
upstream, in between, or downstream of the deleted regions. Since the translation
start site is located in exon 2, it is possible that some small amounts ofFitx3 protein
are made in ak/ak mice. However, since the residual portion of intron 1 cannot be
spliced out due to the missing 5’ spiice site, translation of these transcripts may be
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aberrantly initiated at any ATG triplet contained in the intron, possibly leading to no
or aberrant protein formation [119].
The relevance of the human homologue PITX3, that is iocated in the q24-25
region of chromosome 10, was addressed for individuais with various eye anomalies
[111]. Two mutations were identified in independent patients. A 17 bp insertion in
the 3’ end of the coding sequence, resulting in a frameshifi, occurred in a patient
with anterior segment mesenchymal dysgenesis (A$MD) and cataracts, and a
guanine to adenine substitution, changing a codon for serine into a codon for
asparagine, in the 5’ end of the gene occurred in a patient with autosomal dominant
congenital cataract (ADCC) [111]. The mutations affect regions outside of the HD in
the N-terminal or C-terminal end of the protein and resuit in different phenotypes.
These protein regions are thought to be involved in complex protein-protein
interactions, imparting specificity and efficiency to HD protein function [120].
Functional studies are required to provide further insights into the mechanisms
giving rise to the specific manifestations of these mutations. Ail the affected
individuals from the ASMD family had cataracts of differing severity, suggesting
that development of cataracts in A$MD patients might be a dominant feature
associated with mutations in FITX3 [111]. This is consistent with the strong
expression ofFitx3 during lens development.
2.3.3.2.3 Pitx3 in MesDA development
The neural expression pattem of Pitx3 strongly suggests that it may be
involved in development andlor maintenance of MesDA neurons and analysis of the
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$N of PD patients revealed a reduced density of Fitx3-expressing neurons as
compared to normal controls [14]. In recent celi culture studies, Fitx3 was shown to
activate the TH gene promoter through direct interaction [87, 88], suggesting that
Fitx3 contributes to the regulation of TH expression in MesDA fleurons. Nurri nuil
mutant mice, that fail to generate TH-positive neurons in the mesencephalon, show
at F11 .5 a normal expression pattem of Pitx3, indicating that Fitx3 expression is
independent of Nurr] and insufficient for proper MesDA neuron differentiation [76,
78]. In E12.5 Lmxlb nuli mutant mice, TH-positive Pitx3-negative ceils are
generated in the ventral tegmentum indicating that Lmx]b and Fitx3 are not
necessary for TH expression [52]. In these embryos, only a small number of
aberrantly located Pitx3-positive ceils was identified, posterior and dorsal to the TH
positive celis. From E16 however, no 1H-positive neurons were present in the
region [52] and Lmx]b nuli mutants die as neonates (Michael et al. 1988). A
molecular cascade involving Lrnxlb and Pitx3 thus seems to be tied to aspects of
neuronal specification other than neurotransmitter phenotype, in particular suwival
ofMesDA fleurons.
The role of Fitx3 in MesDA development has flot yet been addressed by
detailed neurological analysis of humans heterozygous for a mutation in the gene or
by creation of Fitx3 nuil-mutant mice. No apparent neurological abnormalities were
reported in the ASMD and ADCC patients mentioned above [111]. Whether the
spontaneously occurring ak mouse mutant is also, as in the eye, a severely affected
hypomorphic or nuil allele for Fitx3 at the brain level remains to be determined. If
so, this mutant might be a very useful mode! to study the role of Pitx3 in MesDA
development. The characteristics of neural Fitx3 expression are remarkable and the
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data from Lmx]b nuli mutant mice suggest that Fitx3 might be implicated in ifie
survival of MesDA neurons. Degeneration of these neurons is a hallmark of PD [8].
If the ak mouse mutant tums out to have severely affected Fitx3 expression in
MesDA fleurons, it might provide a useftil model for further research on (genetic)
causes ofPD.
3. Parkinson ‘s disease
3.1 General introduction
More than 180 years ago, lames Parkinson first described the disorder that
stiil bears bis name t121]. The classic triad of major signs of PD is made up of
slowly progressive resting tremor, rigidity and bradykinesialakinesia and the
diagnosis is made on the basis of these clinical criteria. The disease is an important
public health problem with a prevalence of —1% at 65 years of age, increasing to 4-
5% by the age of 25, affecting millions ofpeople worldwide [122, 123]. The impact
of the disease is indicated by the fact that mortality is two to five times as high
among affected persons as among age-matched controls, resulting in a marked
reduction in life expectancy [124-126]. Thus, PD greatly shortens life as well as
causing debility during life.
Although there are rare familial forms of PD, the majority of PD is sporadic
and its specific etiology is unlmown. There is, however, evidence for a role of both
genetic and environmental factors, for example exposure to pesticides, farming, well
water and rural living [127].
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PD is characterized by the progressive death of selected but heterogeneous
populations of neurons, most importantly the neuromelanin-laden dopaminergic
neurons ofthe SNc and, although less affected, the VIA. Other affected regions are
selected aminergic brainstem nuclei (both catecholaminergic and serotoninergic), the
cholinergic nucleus basalis of Meynert, hypothalamic neurons and small cortical
neurons (particularly in the cingulated gyrus and entorhinal cortex), as well as the
olfactory bulb, sympathetic ganglia and parasympathetic neurons in the gut. Within
the $Nc, neuronal loss tends to be greatest in the ventrolateral tier (loss is estimated
to be 60-70% at the onset of symptoms) followed by the medial ventral tier, with the
dorsal tier relatively spared [8, 128]. This pattem of celi loss is specific to PD; it is
opposite of that seen in normal aging and differs from pattems found in striatonigral
degeneration and progressive supranuclear palsy. Recently, it was shown that
Calbindin D2$K, a well lmown member of the class of calcium-binding proteins,
specifically marks the dorsal tier of the SNc, i.e. those nigral compartments that are
the least affected by the PD celi loss t129, 130]. There is thus the recognition that
the regions most affected in PD form discrete and identifiable units. This raises the
possibility that (j) variable amounts of exogenous or endogenous toxins throughout
the SNc, (ii) variable defense mechanisms against these, (iii) variable expression of
genes implicated in the disease process or combinations of these form the basis of
the stereotypic celi loss in PD.
The selective neuronal loss results in regional loss of striatal DA, most
prominently in the dorsal and intermediate subdivisions of the putamen [131]. This
DA-deficient state is associated with increased activity of the inhibitory GABA
employing (GABAergic) output nuclei in the basal ganglia, i.e. the intemal segment
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of the globus pallidus (GPi) and the SNr. The heightened action of ffie GPi and SNr
is thought to arise from at least two mechanisms: reduced inhibition by a “direct”
GABAergic connection from the striatum (caudate nucleus and putamen) and
excessive excitation through an “indirect” pathway that contains two inhibitory
neuronal connections, the flrst from the striatum to the extemal segment of the
globus pallidus (GPe), and the second from that segment to the STN. The STN
excites the GPi and the SNr by means of the neurotransmifter glutamate. Because
the GPi and $Nr use the inhibitory neurotransmitter GABA, the increased output of
the basal ganglia leads to excessive inhibition and, effectively, to a shutdown of the
thalamic and brainstem nuclei that receive their outflow. The excessive thalamic
inhibition leads to suppression of the cortical motor system, possibly resulting in
akinesia, rigidity and tremor, whereas the inhibitory descending projection to
brainstem locomotor areas may contribute to abnormalities of gait and posture [127,
132-134].
Another important pathological feature is the presence of degenerating
ubiquitin-positive neuronal processes in ceil bodies and neurites, Lewy bodies; these
eosinophilic hyaline inclusions that contain an accumulation of filaments and
granular material with a dense core and loose radiating peripheral filaments are
consistently observed in the selectively vuinerable neuronal populations [135]. The
mechanism of Lewy-body formation, the importance of Lewy bodies to the
pathogenesis of PD and their role in the neurodegenerative process are largely
unknown [136].
The mechanisms responsible for cell death in PD are also largely unknown.
In addition to the presence of Lewy bodies, postmortem examination of affected
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brains of sporadic PD patients showed increased oxidative stress such as glutathione
depletion, iron deposition, increased markers of lipid peroxidation, oxidative DNA
change and protein oxidation [137]. Another key postmortem finding is decreased
expression and activity of mitochondrial complex I in the midbrain. This defect is
specific, as it does not occur in other brain areas and it has not been observed in
other neurodegenerative diseases. Other components of the mitochondrial
respiratory chain are unaffected in PD. Thus, in sporadic PD, oxidative stress and
mitochondrial dysfunction appear to play prominent roles in the death of DA
neurons in the SNc [137]. Increasing evidence suggests that this death may be
apoptotic [13$], but this notion is not universally accepted [139]. A critical question
remains why specific neurons are selectively vuinerable in PD. Besides the afready
mentioned mitochondrial dysfunction, a possible answer may lie in their ability to
take up both endogenous and extrinsic toxic components through selective camer
mechanisms, such as the DAT. Other possible explanations include their increased
metabolic stress, high physiologic rates of protein oxidation, selective generation of
potential toxins or failure to detoxify or dispose them and specific requirements for
neurotrophic support.
3.2 Genetic causes of Parkinson’s disease
There is increasing evidence that genetic factors have an important role in
PD, even in the most conmion sporadic cases of the disease. Earlier studies of twins
were originally believed to have excluded an important genetic contribution to PD,
since they failed to show a higlier concordance among monozygotic twins (MZT)
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than among dizygotic twins (DZT) [140]. However, several unes of evidence have
suggested the need for a reconsideration of this issue. A recent large study, for
example, found high rates of concordance among MZT when one twin had young
onset disease, i.e. before 40 years of age [141]. A study using ‘8f-Dopa and positron
emission tomography (PET) to study dopaminergic function in twin pairs at baseline
clinically discordant for PD, showed that concordance levels for dopaminergic
dysfunction were signiflcantly higher in MZT than in DZT with both no apparent
history of familial aggregation of the disease [142]. furthermore, the level of
concordance in MZT increased with time and 33% of MZ cotwins with abnormal
baseline scans subsequently became concordant for clinical PD, supporting the
assumption that the nigrostriatal dopaminergic dysfunction identified by ‘8F-Dopa
PET represents subclinical manifestation of the disease [142]. Epidemiological
studies have found that, apart from age, a family history of PD is the strongest
predictor of an increased risk of the disease [143], although the role of shared
environmental exposure in some families must be considered. A recent population
based study on Iceland showed that patients with both young- and late-onset (i.e.
onset >50 years of age) PD were signiflcantly more related to each other than
matched groups ofcontrols [144].
Until recently, evaluations of candidate genes involved in the DA system in
families with multiple PD patients and in patients with apparently sporadic PD were
generally unrewarding. A major breakthrough in this field recently came with the
identification of two distinct mutations in the a-synuclein gene ($NCA), located on
chromosome 4q, in several families with autosomal dominant forms of PD. One
mutation, Alanine53lhreonine (Ala53Thr), was reported in a single large Italian
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family with very high penetrance (roughly 90 percent) and three smaller Greek
families that may be very distantly related [145], and the other, Alanine30Proline
(Ala3OPro), was reported in a family of German origin [146]. Œ-Synuclein is a
highly conserved, abundant 140-amino-acid protein of unlmown function that is
expressed mainiy in presynaptic nerve terminais in the brain [147]. Lewy bodies are
consistently stained with antibodies to Œ-synuclein [148]. Several other studies have,
however, failed to detect mutations in SNCA in a large number of other families
[146, 149, 150], and in sporadic cases [146], suggesting that PD is only rarely
caused by such mutations. Another breakthrough was the identification of two
mutations in the parkin gene, located on chromosome 6q, in four unrelated Japanese
families with autosomal recessive juvenile parkinsonism. In one family, five out of
twelve exons were deieted, the three other families had a deletion affecting exon 4
alone [151]. Parkin is similar to the ubiquitin families of proteins, which are
involved in the pathogenesis of severai neurodegenerative diseases and are a
component of the paired helical filaments in Alzheimer’s disease [152-154] and of
Lewy bodies in PD [155-157]. Recent investigations suggest that missense
mutations in parkin can also cause PD that appears indistinguishable from sporadic
PD [158]. These observations promise to provide important insights into the
pathogenesis ofnigral degeneration and Lewy-body pathology.
Although the debate whether PD is caused by environmental agents,
hereditary factors, or a combination of both has flot finished, studies from the recent
past have shown overwhelming evidence for a role of genetic factors in
susceptibility to PD, in both the familial and sporadic cases of the disease. The
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general goal of current genetic studies in the area of PD is to fmd putative
susceptibiiity genes.
3.3 Experimental and animal models ofParkinson’s disease
In many neurodegenerative disorders, animal modeis have provided
tremendous insight and dues into the pathogenesis of these disorders. For direct
relevance to human PD, an ideai animal model for this disease should have the
foliowing characteristics: first, a “clinicaily” normal complement of DA neurons at
birth with selective and graduai loss of DA neurons commencing in (early)
aduithood. The losses shouid exceed 50% and be readily detectable using
biochemistry and neuropathology. Second, the model should have easily detectable
motor deficits, including the cardinal features of PD, which are
bradykinesialaldnesia, rigidity and resting tremor. Third, the model should show the
deveiopment of characteristic Lewy bodies. Fourth, if the model is genetic, it should
be based on a single mutation to allow robust propagation of the mutation, as weli as
crossing with enhancer or suppressor strains. Last, it should have a relativeiy short
disease course of a few months, aliowing rapid and less costly screening of
therapeutic agents.
The first agent used to model PD was 6-hydroxydopamine (6-OHDA). Afier
injection into the striatum or SN, it selectively accumulates in DA neurons and kilÏs
them owing to toxicity that is thought to invoive the generation of free radicals. 6-
OHDA is an effective toxin in rats, mice, cats and primates that has been
predominantly used to produce uniiaterai lesions. In rats, the extent ofDA depletion
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can then be assessed by examining rotatory behaviour in response to amphetamine
and apomorphine [159]. It has therefore proved to be useful for phannacological
screening of agents that have effects on DA and its receptors. 6-ORDA lesions do
flot resuit in Lewy bodies and can produce non-specific damage to other fleurons.
Betarbet and colleagues produced a model of PD by infusing rats
intravenously with rotenone [160], a naturally occurring compound from the roots of
certain plant species, which has been used as an insecticide and to kiil or sample fish
populations in lakes or reservoirs. It is known to be a high-affinity specific inhibitor
of mitochondrial complex I. The rats developed a progressive degeneration of
nigrostriatal neurons with a loss of TH, DAT and vesicular monoamine transporter
immunoreactivity. furthermore, the SN neurons showed cytoplasmic inclusions that
were reminiscent of Lewy bodies. The rats showed bradykinesia, postural instability,
unsteady gait and some evidence of tremor, and the deficits improved after treatment
with the DA receptor agonist apomorphine. These findings are remarkable because
they show that an inhibitor of mitochondrial complex I, which acts throughout the
brain, can produce selective degeneration of nigrostriatal neurons, therefore
indicating that SN neurons are particularly vuinerable to these inhibitors. This model
meets most of the criteria needed for an excellent animal model of PD. However, it
suffers from much variability in the susceptibility of individual rats to the toxin. In
the study ofBetarbet and colleagues, only 12 out of 25 rats treated with standardized
doses of rotenone developed lesions [160] and precludes therefore the usefulness of
the model for testing neuroprotective agents. It could be, however, valuable in
examining celi replacement strategies such as transplantation of fetal nigral neurons
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or stem ceils, and it might lead to novel insights into the pathophysiology of the
death of SN neurons in PD.
The best-characterized model of PD has been developed by using the
neurotoxin 1 -methyl-4-phenyl-1,2,3 ,6-tetrahydropyridine (IVIPTP) [161]. The
discovery of MPTP occurred in 1982 when a group of drug addicts in Califomia
developed subacute onset of severe parldnsonism. Investigation revealed that the
syndrome was caused by self-administration of a synthetic heroin analogue that had
been contaminated by a byproduct, MPTP, during manufacture. MPTP
administration was subsequently shown to model PD in both mice and primates.
MPTP toxicity in primates replicates ail the clinical signs of PD, including resting
tremor, rigidity, akinesia and postural instability [161, 162], and has been very
useful for studying the striatal circuitry involved in PD pathophysioiogy. Primates
treated with MPTP show an excellent response to L-DOPA and dopamine receptor
agonists. As in PD, the SNc neurons are particularly vulnerable, whereas VTA
neurons are more resistant. The toxin also causes a loss of locus coeruleus fleurons,
celis that are also lost in PD [163]. It is not entirely clear how MPTP administration
leads to neuronal death. Intracellular 1-methyl-4-phenylpyridinium (MPPj, MPTP’s
active metabolite, inhibits mitochondrial complex I [164] and increases the
production of free radicals [165]. There is experimental evidence that this resuits in
ceil death by apoptosis [166-169], but also a possible role for inflammation in the
pathogenesis of MPTP toxicity has been suggested [170-172]. The DA neuron
selectivity of MPTP neurotoxicity is thought to stem in part from the conversion of
MPTP by monoamine oxidase B, also implicated in DA catabolism, and from avid
affinity of Mpp for the DAT. In aged MPTP-treated primates, there were neuronal
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inclusions that partially resembled Lewy bodies [173], but typical
electronmicroscopie features were flot observed [174]. The main difficulty with
MPTP toxicity as a model of PD, however, is that it is an acute or subacute process,
whereas PD is a slowly progressive illness that evolves over years. With this in
mmd, chronic administration of MPTP in primates using several dosing regimes has
been shown to produce slow evolution of a parkinsonian syndrome, with uneven
striatal DA fibre loss and more selective depletion of SN neurons [163, 175-177].
The MPTP animal model has been extremely valuable in testing neuroprotective and
neurorestorative strategies [178-183], and many ofthese discoveries are currently in
various stages of therapeutic development [137, 184]. The most striking difference
with PD is the lack of Lewy body formation, but it seems that more chronic
administration of MPTP could produce Lewy bodies, similarly to chronic
administration of rotenone [185].
The spontaneously occurring weaver (wv) mouse mutant suffers from severe
ataxia that is obvious by about the second post-natal week [1 86]. Wv/wv mutant
mice are characterized by a cerebellum that is drastically reduced in size due to
depletion ofthe major cell type ofthe cerebellum, the granule ceil neuron [187-189].
The precursors to granule celi neurons in the cerebellar extemal germinal layer
(EGL) are present at birth and are apparently normal [189]. However, rather than
leaving the EGL during the first post-natal week, the precursors die in situ. The wv
locus is on mouse chromosome 16 and was recently shown to have a single base
pair substitution mutation in the Girk2 gene, a potassium channel gene that is
expressed in the brain [190, 191]. The mutation affects a highly conserved domain
of the voltage-gated, calcium dependent and inward rectifying families of potassium
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channeis [192], thereby eliminating channel conductance or aitering ion seiectivity
[193-197]. Beside the cerebeilar phenotype, weaver mice also have a number of
other defects. Interestingiy, dopaminergic input to the striatum is iost during the first
few weeks afier birth due to the death of DA neurons in the SN [198]. In addition,
male homozygous mice are sterile [199] and both heterozygous and homozygous
animais undergo sporadic tonic-cionic seizures [200]. At birth, wv/wv mice have
normai numbers of MesDA fleurons, but at P3 some deficit in dopaminergic uptake
occurs [201, 202], indicating that these normaiiy generated and migrated neurons
already have functional deficits. By P7, abnormalities in the neurites of TH-positive
neurons are evident in the wv/wv SN [203]. By P20, approximateiy 42% of the 1H-
positive neurons in the wv/wv SN have degenerated, with ail the SN subdivisions
involved, whereas the VIA is then stili unaffected t204]. By P90, the $N ceil ioss is
69% and the VIA ceil ioss 26% [204]. 3H Thymidine autoradiography of MesDA
neurogenesis showed that iate-generated MesDA neurons, i.e. generated on E12 and
E 13, are more vuinerable to weaver gene action than those that are generated earlier
[202]. Taken together, these data suggest that the weaver potassium channei
mutation may have an effect on neurite function and formation that precedes the
later obsewed ceil death of postmitotic MesDA neurons and may even influence its
occurrence. Wv/wv mice represent thus far the only naturaliy occurring animai
modei of genetically determined nigrostriatal deficiency. Research on this mouse
mutant has reveaied important information, especialiy on MesDA neurogenesis.
However, the concomitant severe cerebeilar pathology with associated locomotor
dysfunction, makes this mutant not very suitabie as animai modei for PD, a disease
that finds most of its etioiogy in the midbrain.
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As mentioned earlier, mutations in a-synuclein are related to PD in some
pedigrees. A novel model of PD was recently produced by expressing mutant and
normal forms of Œ-synuclein in Drosophila [205]. The flues showed an age
dependent loss of dorsomedial neurons that stained for TH, with no difference in the
toxicity of wildtype and mutant Œ-synuclein. Other subsets of DA neurons, however,
showed no abnormalities, consistent with the differential vulnerability of DA
neurons in human PD, and cortical neurons and serotonin neurons were spared. In
addition, Œ-synuclein-stained inclusions were observed in neurons, which resembled
Lewy bodies. The flues developed locomotor dysfunction with age, but it was not
determined whether these are due to dysfunction of DA fleurons, nor if these deficits
could be reversed by the use of DA receptor agonists. There was also retinal
degeneration, which is not a typical feature ofPD, but this could be a unique feature
of the Drosophila mode!. The well-characterized genetics of Drosophila will allow
the rapid characterization of enhancer and suppressor mutations and it is without
doubt that this model will teach us much about the pathogenesis of Œ-synuclein
induced neurodegeneration in flues. However, the challenge will be to verify
potential neuroprotective agents and genetic modiflers in human PD.
A number of transgenic mice models overexpressing human Œ-synuclein
have been developed. While none of these mice accurately model PD, a number of
the models exhibit significant synucleinopathy-induced neurodegeneration, thus
modelling characteristics of human Œ-synuclein pathology. Expression of human
wildtype or Ala53Thr Œ-synuclein using the Thyl promoter that directs fleuron
specific expression but no expression in SN neurons, resulted in increased ci
synuclein staining in ±80% of motor neurons (some also showing Lewy-body-like
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pathoiogy) with significant degeneration of neuromuscular junctions and axonal
degeneration [206]. The mice exhibited a progressive ioss of motor function, but it
was not determined whether there was ioss of DA neurons nor whether the motor
deficit was responsive to DA receptor agonists. Mice overexpressing wildtype ci
synuclein, using the platelet-derived growth factor promoter, develop a progressive
accumulation of ci-synuclein- and ubiquitin-immunoreactive inclusions in the
neocortex, hippocampus and SN [207]. However, there were both cytoplasmic and
nuclear inclusions, and the latter are flot a typical feature ofPD. Besides, no fibrillar
aggregates that are characteristic of Lewy bodies were seen. There was no loss of
DA neurons within the SN, but there was a ioss of DA terminais in the transgenic
une with the highest expression level. There was also a decrease in TH protein levels
and activity, although DA levels were flot measured. The mice suffered postural
instability at one year, but it was flot determined if these deficits were reversible
with DA receptor agonists. Mice expressing human Ala53Thr mutant ci-synuclem,
but not wildtype or Ala3OPro mutant, under the control of the mouse pnon protein
promoter (PrP) develop an adult-onset neurodegenerative disease with progressive
motor dysfimction leading to death [208, 209]. The neurological dysfunction was
associated with age-dependent intracytoplasmic neuronal accumulation of ci
synuclein and pathological neuronal accumulations of ubiquitin. Besides, the ci
synuclein inclusions contained 10-16 nm wide fibrils similar to human Lewy bodies
[209]. However, it remains to be determined whether the mouse PrP human
Ala53Thr ci-synuclein transgenic mice exhibit DA neuron loss and whether the
neuroiogical deficits can 5e reversed by the use of DA receptor agonists. Although
overali, the resuits from the various ci-synuclein transgenic mice studies indicate that
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formation of a-synuciein aggregates is associated with some neurodegenerative
characteristics, none of the modeis have yet shown to have significant abnormalities
in DA neurons. It is conceivable that rodent DA neurons are resistant to Œ-synuclein
toxicity and that higher levels are needed to achieve Œ-synucleinopathy-induced PD.
Consistent with this notion is the observation that stable, viraily mediated
overexpression of human wildtype and Ala53Tbr mutant Œ-synuciein with adeno
associated virus in SNc neurons of rats leads to progressive age-dependent loss of
DA neurons, motor impairment and Œ-synuclein-positive cytoplasmic inclusions
[210].
As it is iikeiy that PD wiil prove to be heterogeneous in its aetiology, with
genetic factors predominating in some cases, and environmentai factors in others, it
is as yet unclear wheffier toxic or genetic modeis will prove to be most useful as
animal model of PD. None of the currently available models recapitulate ail of the
key clinical and neuropathoiogical features of PD. Because each of the modeis does
recapitulate significant features of PD and represents parts of the same puzzle,
combinatorial study of multiple models are warranted to provide a more fuily
deveioped view of PD pathogenesis. An important question that remains to be
answered is why PD ravages the SNc in such a stereotypic manner with the ventral
tier most affected and the dorsal tier relativeiy spared. None of the currently
avaiiable animai models has accurately copied this pattem of SNc ceil loss and
beside the observation of Caibindin D2$K specificaiiy marking the dorsal tier of the
SNc in humans, no genetic markers that define specific subsets of SNc neurons have
yet been identified.
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II RESULTS
1. Project descr;ption
There is no data in the literature exploring the in vivo role of Fitx3 in
MesDA development. The only developmental data on neural Pitx3 currently
available is descriptive, showing expression in the MesDA system [14] and
analysing Pitx3 expression pattem in MesDA progenitor celis in Nurri and Lrnx]b
knockout mice [52, 76, 78]. These data indicate that neural Fitx3 expression is
confined to MesDA neurons, independent of Nurri, dependent and possibly
downstream of Lmx]b, insufficient for proper MesDA neuron differentiation but
possibly implicated in aspects of neuronal specification other than neurotransmitter
phenotype, in particular suwival of MesDA neurons [52, 76, 78]. The role of Fitx3
in MesDA development has flot yet been addressed by creation and analysis ofFitx3
nuil-mutant mice. The spontaneously occurring ak mouse mutant has recently been
identified as a severely affected hypomorphic or nuli allele for Pitx3 during eye
development. During my Master’ s studies, I have analysed neural Fitx3 expression
in ak mice and, whule using this mouse mutant as a hypomorphic or nuli allele for
Pitx3 at the brain level, analysed the in vivo role offitx3 in MesDA development.
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Résumé
Les neurones dopaminergiques mésencéphaliques (MesDA) jouent un rôle
critique dans les processus moteurs et comportementaux. Dans la maladie de
Parkinson, leur perte résulte en une déficience en dopamine au niveau du striatum et
un trouble locomoteur hypokinésique. Le gène à boîte homéo Pitx3 est exprimé dans
les neurones dopaminergiques mésencéphaliques. Nous montrons maintenant qu’un
seul sous-groupe de ces neurones exprime Fitx3 et que dans la souris aphakia
déficiente en Fitx3, ce sous-groupe disparaît progressivement par apoptose durant le
développement fétal (substantia nigra) et post-natal (ventral tegmental area),
résultant un niveau très bas de dopamine dans le striatum et une hypokinésie. De
façon semblable à la forme de maladie de Parkinson humaine, les neurones dorsaux
de la substantia nigra (négatifs pour Fitx3) sont épargnés chez la souris mutante.
Ainsi, Pitx3 définit une voie de survie pour les neurones qui sont impliqués dans la
maladie de Parkinson et qui sont requis pour l’activité locomotrice spontanée.
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Abstract
Mesencephalic dopaminergic (MesDA) neurons play critical roles in motor
and behavioral processes; their loss in Parldnson’s disease (PD) resuits in striatal
dopamine (DA) deficiency and hypokinetic movement disorder. The Pitx3
homeobox gene is expressed in the MesDA system. We now show that only a subset
of MesDA neurons express Fitx3 and that in Pitx3-deficient aphalda mice, this
subset is progressively lost by apoptosis during fetal (substantia nigra, SN) and post
natal (ventral tegmental area) development, resulting in very low striatal DA and
hypokinesia. Similar to human PD, dorsal SN neurons (which are Pitx3 negative) are
spared in mutant mice. Thus, Pitx3 defines a pathway for survival of neurons that
are implicated in PD and that are required for spontaneous locomotor activity.
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Intoduction
The physiological role and clinical relevance of mesencephalic dopaminergic
(MesDA) neurons are well recognized in schizophrenia, addictive behavioural
disorders (Egan and Weinberger, 1997; $wanson et al., 199$) and, most importantly,
Parkinson’s disease (PD). Rare cases of familial PD have been linked to mutations
in the a-synuclein and Parldn genes (Polymeropoulos et al., 1997; Kitada et al.,
199$), but the cause of the commonly encountered sporadic cases is unknown.
Studies in twins and relatives of sporadic cases, however, suggest that susceptibility
to the disorder might be predisposed prenatally (Tanner et al., 1999; Piccini et al.,
1999; Montgomery, Jr. et al., 1999; Sveinbjomsdottir et al., 2000), highlighting the
importance of genes that control development andlor maintenance of MesDA
fleurons.
MesDA neurons are located in the ventral midbrain to form the substantia
nigra (SN) and ventral tegmental area (VTA). Differentiation and anatomical
localization of MesDA neurons are dependent on the action of various diffusibÏe
factors and transcription factors. MesDA neurons develop at sites where the signals
of Sonic hedgehog (Shh) and Fgf intersect, both being necessary and sufficient for
induction of DA neurons (Ye et al., 1998). Before expression of DA-specific
markers, early ventral midbrain markers like En]/2, Lrnxlb, Pax2/5 and Wnt] are
expressed in these celis (Hynes and Rosenthal, 1999; Smidt et al., 2000). The
appearance of the key enzyme in DA synthesis, tyrosine hydroxylase (TH) at
embryonic day 11.5 (El 1.5) of mouse development shortly follows expression of the
orphan nuclear receptor Nurrl (Nr4a2 — Mouse Genome informatics) (E 10.5) and of
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the homeobox gene Fitx3 (El 1). The expression of Nurri is not restricted to
MesDA neurons and extends in a large field in the mesencephalon and diencephalon
(Zetterstrom et al., 1996). Nurr] nuil mutant mice fail to induce TH in MesDA
progenitor neurons and die soon after birth (Zetterstrom et al., 1997). Whether these
progenitors are lost during late fetal development or maintained post-natally is not
entirely clear yet (Saucedo-Cardenas et al., 199$; Witta et al., 2000).
Fitx3 expression is, at the brain level, confined to MesDA neurons and is
maintained throughout aduit life in both rodents and humans (Smidt et al., 1997).
Extraneural Fitx3 expression was shown in the eye, where it is present in the
developing lens (Semina et al., 1997). In humans, mutations of the PITX3 gene
were found in two families with inherited forms of cataracts and antenor segment
mesenchymal dysgenesis (Semina et al., 1998). Similarly, abnormal eye lens
development was observed in a naturally occurring mouse mutant, the aphakia (ak)
mouse, which has two 5’ deletions in the Fitx3 gene (Rieger et al., 2001), including
one that deletes exoni.
We now show that Fitx3 is only expressed in the ventral tier of the SN pars
compacta (vSNc) and in about haif of the VTA DA neurons. In ak mice, we show
undetectable midbrain Pibc3 expression, selective degeneration of vSNc DA neurons
as well as of roughly haif VTA neurons and greater than 90% decrease in dorsal
striatal DA levels in association with marked reduction in spontaneous locomotor
activity. The strong correlation between Fitx3-expressing 1H neurons and neuronal
losses in ak mice or in individuals with PD patients suggests that Fitx3 defines the
neuronal population that is more susceptible to degeneration in PD. Ak mice thus
represent a highly specific mouse model of neuronal loss in human PD.
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Materials and Methods
Animais
The ak mice originate from The Jackson Laboratories. The autosomal recessive ak
mutation arose spontaneously in the 129/Sv-Sl strain (Varnum and Stevens, 1968)
and was subsequently crossed into the C57BL16 background (Semina et al., 2000).
The mice used in this study were maintained in the C57BL/6 background and
provided to us by Dr. Jeff Murray, University of Iowa. C57BL/6 mice were used as
wild-type mice. For timed breeding experiments, mice were mated and the moming
a vaginal plug was detected was considered to be E0.5.
Brai» preparation and immunohistochemistry
Male Pi, P21, P50 and P100 wild-type and ak mice were transcardially perfused
with buffered 4% paraformaldehyde. Brains were collected, postfixed for 24 h and
embedded in paraffin (P50) or cryoprotected in 30% sucrose for an additional 48 h
(Pi, P21 and P100). P50 midbrain-containing sections (5 itm) were mounted and
immunostained for TH and Pitx3. Pi, P21 and P100 brains were cut into 50-iim
coronal sections encompassing the entire striatum and midbrain using a freezing
microtome. free-floating sections were collected for imrnunohistochemistry as
separate sets so that each set contained every third serial section. One set of sections
was immunostained for TH, another set was processed using 0.1% Cresyl Violet as a
Nissi stain. Rostrocaudal position of sections was assessed with the aid ofthe mouse
brain atlas of Franklin and Paxinos (Franklin and Paxinos G., 1997). For embryos,
pregnant mothers were perfused transcardially with 4% paraformaldehyde.
Embryos were dissected and their heads were postfixed for 24 h and embedded in
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paraffin. Midbrain-containing sections (5 jim) were mounted and immunostained
forTH.
linmunostaining was performed using an avidin-biotin-peroxidase complex
(ABC) method and a fluoresceinlrhodamine-fluorochrome labelling method.
Antibodies and dilutions used: anti-Pitx3 (Lebel et al., 2001), 1:10; anti-TH
(Chemicon polyclonal 1:100); anti-1H (Immunostar monoclonal 1:1000). Confocal
microscopy was performed using a Zeiss LSM5 10 instrument. Apoptotic ceils were
identified using the Apoptag kit from Intergen according to the manufacture?s
recommendations. Percentage apoptotic ceil was calculated relative to nuclei
counted on Nissl-stained sections.
Stereology and quantitative morphology
Unbiased estimates of midbrain DA neurons were obtained using the optical
dissector method of West and Gundersen (West and Gundersen, 1990; West, 1993).
The entire rostro-caudal extent of the midbrain was examined in a 1:3 series of TH
stained coronal sections using an Olympus BX-40 microscope equipped with a
motorized XYZ stage and Stereoinvestigator software (Microbrightfield Inc.). The
SN and VIA were traced at low power (lOx). 1H celi counts were performed at
lOOx magnification (oil, NA 1.3) using a 60 x 60 im counting frame. A 10 tm
dissector was placed 2 iim below the surface of the section at counting sites located
at 150 iim intervals after a random start.
Ceil densities within SNc and VIA were determined in cresyl violet stained
sections delineated according to adjacent TH-stained sections. Nissl-stained profiles
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greater than 7 im in diameter were counted. Total profile counts were then divided
by SNc or VTA surface area estimated with the Stereolnvestigator sofiware.
Locomotor activity measurements
Male wild-type and ak mice of approximately 115 days old were maintained in
standard animal housing conditions with a 12 h light-dark cycle and lights on at 6
a.m. Tests were carried out between 4 p.m. and 3 p.m. the next day. At 3.30 p.m.,
mice were placed in the 43 X 43 cm Plexiglas arena of the Opto-Varimex-3
photoceil-base monitor (Columbus Instruments) with water and food freely
available, and recordings started 30 minutes later. The Opto-Varimex-3 animal
activity monitor employs a 15 X 15 photoceli beam grid to measure spontaneous
ambulatory and stereotypic activities like grooming, scratching and other non
ambulatory activities (as well as the amount of time spent on these activities) by
separating beam interruptions associated with ambulatory activity from total
activity.
Dopamine quantitation
Male wildtype and ak mice of approximately 130 days old were analyzed for
postmortem tissue content of DA. Afier cervical dislocation, brains were cut into 1
mm sections on an ice-cold dissection plate; dorsal and ventral striatum were
collected from two sections per brain with a biopsy punch (0.5 mm diameter).
Homogenization of brain samples and DA quantitation by reverse-phase HPLC with
electrochemical detection were done as described previously (Ste-Marie et al.,
1999). Protein content was determined using the BCA assay in order to normalize
dopamine context.
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Resuits and Dîscussion
Loss of Pitx3-positive 1H-positive neurons in aphakia mice
To test whether ak mice are deficient in midbrain Pitx3 expression, we assessed
Pitx3 levels using an antibody against Pitx3 in matched coronal sections through the
midbrain of young aduit (postnatal day 50, P50) ak and wildtype mice. Cytoplasmic
TH (Fig. lA) and nuclear Pitx3 (Fig. ÏC,E) immunostained the same midbrain
region in wild-type mice, whereas no Pitx3-immunoreactive celis were found in the
midbrain of ak mice (Fig. 1D). A marked reduction of the MesDA system was also
noted in ak mice (compare Fig. lB with lA). In order to document these differences
precisely, serial midbrain sections of P100 mice were systematically analyzed for
TH-immunoreactivity (Fig. 1F-K). The MesDA system includes the SN (Fig. 1F,H)
and VTA (Fig. 1H,J). The SN is subdivided into pars reticulata (SNr) and compacta
(SNc), with the latter containing the majority of 1H-positive celi bodies (Fig. 1F).
In ak mice, SNr and most of SNc are depleted of TH-positive fibers and ceils,
respectively (Fig. 1G), with the exception ofthe dorsal tier ofthe SNc (dSNc) where
TH-positive ceils are preserved (Fig. 1I,K). The VTA is also affected, but to a lesser
degree (Fig. 1I,K). To obtain an unbiased estimate of the number of TH-positive
neurons in the $N and VIA, we performed stereological analysis on serial sections
throughout the entire midbrain of wiÏd-type and ak mice. Total TH-positive ceils
were reduced by 71% in the SN and by 52% in the VIA of ak mice compared to
wild type (Fig. iL). b determine whether there is an actual loss ofneurons or only
of 1H expression, total neuron densities were evaluated in Nissl-stained sections.
This analysis showed a 57% reduction of Nissl-stained neurons in the $Nc and a
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34% reduction in the VIA (Fig. 1M). Ihe strong correlation between numbers of
TH-positive celis and neuronal densities (Nissi) indicates a net loss of MesDA
neurons in ak mice. The maintenance of 1H-positive neurons in the dSNc of ak
mice is provocative in the context of human PD where relative sparing of these
neurons also occurs (Feamley and Lees, 1991). In this context, we re-evaluated the
expression of Pitx3 in the MesDA system. This analysis revealed that Pitx3 and 1H
are co-expressed only in a subset of SN and VIA neurons. Pitx3-positive neurons
account for most TH-positive neurons in the ventral SNc (fig. iN) and for about
half of the 1H-positive neurons in the VIA, where boffi populations are
intermingled (fig. 10). In the SN, Pitx3-positive DA neurons are essentially those
of the ventral tier, whereas the dSNc largely contains Pitx3-negative TH-positive
fleurons. These studies thus show that the MesDA system is composed of two
previously unrecognized neuronal subpopulations that are differentiated by
expression of Fitx3. The perfect correlation between Pitx3 expression and neuronal
losses in ak mice strongly suggests that Pitx3 is required for development andlor
maintenance of the Pitx3-expressing subset of neurons. This strong correlation is
also consistent with the exclusion of other genes of the ak locus in the phenotype of
ak mice. Jndeed, expression of the Gbfl gene is not affected in ak mice and that of
Cig3O is only reduced by about 50% (Rieger et al., 2001); this latter gene is
primarily expressed in liver and skin and codes for a protein that is implicated in
long-chain fatty acid rythms (Tvrdik et al., 1997).
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Pitx3 serves a maintenance function
In order to address the origin of neuronal deficit in ak mice, we analyzed the
developing MesDA system. At E12.5, most MesDA neurons have been formed
(Bayer et al., 1995) and during the post-natal period, the MesDA system is
undergoing phenotypic maturation which includes developmental!programmed ceil
death (Jackson-Lewis et al., 2000). 1H immunostaining throughout the E12.5
midbrain did flot show significant differences between ak and wild-type mice (Fig.
2A-H), suggesting that the early developmental processes are flot affected in ak
mice. At Pi, however, the SN of ak mice is almost completely devoid of 1H-
positive celis (compare fig. 21 with 2H), whereas the VIA is flot affected (Fig. 2H-
J). When counted, 1H-positive ceils were found to be reduced by 91% in the Pi $N,
but not in the VIA (Fig. 2J). By P21, 1H-positive celis are reduced by 82% in the
SN and tend to be reduced in the VIA (Fig. 2K). Collectively, these data suggest
that SN 1H-positive neurons disappear during the fetal period, whereas VIA
neurons are lost later with 52% reduction at P100 (Fig. iL).
b assess whether apoptosis contributes to the loss of MesDA ceils in ak
mice, we compared the ftequency of TUNEL-positive celis in the $Nc of Pi ak and
wild-type mice. A significant increase in the frequency of apoptotic ceils was
observed (Fig. 2L), in agreement with neuronal loss in $Nc of Pi mice (Fig. 21).
These data indicate that early differentiation of MesDA neurons is not highly
dependent on the Fitx3 gene as shown in ak mice that carry a strongly hypomorphic
(and possibly nuil) allele of this gene. However, survival of Pitx3-expressing
MesDA neurons requires significant Pitx3 expression. Most sensitive are the v$Nc
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neurons that are severely depleted by birth in ak mice, in contrast to those of the
VTA that are lost later.
Striatal dopamine deficiency
SN dopaminergic neurons project primarily to the dorsal striatum to regulate motor
control, whereas VTA dopaminergic neurons project to the ventral striatum and
modulate emotional behavior (Bj5rldund and Lindvall, 1984). The impact of
MesDA neuronal depletion in ak mice was assessed by immunohistochemical
staining of striatal TH fibers (Fig. 3A,B) and high pressure liquid chromatography
(RPLC) measurement of striatal DA levels (Fig. 3C,D). A dramatic reduction of
dopaminergic innervation was observed in the dorsolateral striatum of ak mice, with
relative sparing in the ventral striatum (compare Fig. 33 with 3A). Corresponding
striatal DA levels were reduced by 93% in the dorsal striatum and by 69% in the
ventral striatum (Fig. 3C,D).
The severe depletion of dorsal striatal DA levels which are supplied from the
vSNc correlates well with the pattem of DA deficiency obsenred in PD patients
(Kish et al., 1988).
Reduced spontaneous Iocomotor activity
We then determined whether ak mice display altered locomotor behavior by
measuring spontaneous ambulatory and stereotypic activities over 23 h periods using
a photoceil grid counter. During the day when mice are normally less active, no
differences were observed between groups (Fig. 4A-E). However, ak mice showed a
marked reduction in ambulatory (Fig. 4A) and stereotypic (Fig. 4D) activities during
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the night, as they walked 71% less than wt (Fig. 43), spent 69% less time walldng
(Fig. 4C), made 53% less stereotypic movements (Fig. 4E) and spent 44% less time
making stereotypic movements (Fig. 4F). Conversely, they spent 38% more time
resting (Fig. 4G,H). In view of the ak mice eye defect, it is interesting to contrast
the reduction of 24 h spontaneous movement in ak mice with the effects of gene
mutations that eliminate circadian rhythms, such as mutations of the Clock or Per]
and Per2 genes (King et al., 1997; Zheng et al., 2001). The latter resuit in loss of
diumal rythmicity, but not in reduction of total movement per 24 h period as
observed in ak mice. Moreover, the speed of spontaneous ambulatory movements
was not different in ak compared to wild type (Fig. 41), suggesting that the ak
mutation and the associated blindness do not impair peripheral motor function.
These resuits indicate that ak mice display marked akinesia.
Pitx3 and neurodegeneratïon in Parkinson’s disease
The ak mice thus recapitulate cardinal features of PD, in particular the akinetic
subtype of PD. Indeed, the preferential loss of vSNc TH-positive neurons taken
together with the severe depletion of dorsal striatal DA levels and the associated
hypokinesia are very similar to the pathogenesis ofPD (Kish et al., 1988; Feamley
and Lees, 1991; Jellinger, 2001). This close similarity raises the possibility that PD
patients are preferentially susceptible to loss of Pitx3-positive rather than Pitx3-
negative MesDA neurons. This hypothesis is supported by previous observations
(Smidt et al., 1997) but will demand further investigation.
Previously reported models of MesDA neuronal deficiency may not be as
selective or as similar to PD. Indeed, Nurr]-deficient mice have complete agenesis
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ofMesDA neurons ami die after birth (Zetterstrom et al., 1997; Saucedo-Cardenas et
al., 1998). Similarly, Lrnx]b-deficient mice have complete loss of MesDA neurons
from El 6, major deficits throughout the midbrain and limb and kidney defects
(Smidt et al., 2000; Chen et aI., 1998). Furthermore, currently available animal
models for PD, whether induced by neurotoxins or by overexpression different
forms of aipha-synuclein or parkin, have flot been able to explain the highly specific
and stereotypic pattern of MesDA ceil loss in human PD, with ventral nigra being
most affected (Dawson et al., 2002). In contrast, the ak mice are only deficient in
this specific subset of MesDA neurons (Fig. 5) and they have normal midbrain
structures. They may thus provide a useful model to test therapies (drugs, cellular or
gene therapy) for PD and to define a molecular mechanism explaining the selective
sensitivity of Pitx3 -expressing MesDA neurons to degeneration.
Finally, the dependence on Pitx3 for survival of Pitx3-positive TH neurons
and the sensitivity of Pitx3-positive MesDA celis to degenerate in PD (Smidt et al.,
1997) suggest that Pitx3-dependent function(s) may relate to the pathogenesis of
human PD. Such fimction or downstream target gene(s) may contribute to control
cell survival/death in development andlor in pathogenesis of the MesDA system.
Further investigation of developmental defects resulting from Pitx3 deficiency may
provide novel insight into disease pathways involved in PD.
Fitx3 gene mutations may be involved in the etiology of diseases that affect
the MesDA system. So far, two PITX3 mutations have been identified in families
with autosomal-dominant cataracts and autosomal-dominant anterior segment
mesenchymal dysgenesis (Semina et al., 1998). These individuals are flot known to
have parkinsonian symptoms. It is noteworthy, however, that both mutations have
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dominant effects in individuals that stili have an intact PITX3 allele. Because a
midbrain phenotype may not 5e expected in hemizygous carriers, as heterozygous ak
mice do not exhibit any phenotype (Vamum and Stevens, 196$) (data flot shown), it
likely that these human mutations cause a dominant effect that may for example,
impair eye-specific protein:protein interactions (Semina et al., 1998). This would be
consistent with their position in the N or C termini of PITX3 rather than in the
homeodomain that has been implicated in many loss-offunction mutations in the
related PITX2 gene (Amendt et al., 1998). Thus, it would be worthwhile to
investigate whether PITX3 allelic polymorpbism can 5e detected in families with
Parkinson’ s disease.
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Legends to Figures
Fig. 1. The aphalda (ak) mice have no detectable Pitx3 and a markedly reduced
midbrain dopaminergic system. (A-D) Adjacent coronal midbrain sections
containing the SN in P50 wild-type (A,C) and ak (B,D) mice immunostained for 1H
(A,B) and Pitx3 (C,D). Rostrocaudal positions are indicated as millimeters relative
to bregma in the lower right corner. (E) High-power view of the SN shown in C,
highlighting the nuclear staining. By confrast, none of the weak background
staining in D was nuclear. (F-K) Equivalent rostral-to-caudal coronal midbrain
sections of P100 wild-type (F,H,J) and ak (G,I,K) mice immunostained for 1H. (L)
Stereological analysis of 1H-positive celis of the lefi SN and VTA in wild-type and
ak mice. The data are represented as the means±s.e.m. (n = 4). (M) Density of
Nissl-stained ccli bodies in the ieft SN and VTA of wild-type and ak mice (n = 4).
A statistically significant decrease in 1H-positive ccli bodies and density of Nissi
stained celi bodies was detected in the SN and VTA ofakmice compared to controls
(P<0.0l, t-test). (N,O) Coronal sections through the right SN (N) and VIA (O) of a
P50 wild-type mouse immunostained for TH (fluorescein-labeled, green) and Pitx3
(rhodamine-labeled, red) analyzed by confocal microscopy. Scale bars: in A, 125
pm for A-D; in F, 250 m for F-K; in E, 30 jim for E; in N and 0, 30 pm.
Fig. 2. 1H-positive MesDA neurons are lost primarily during fetal period for the
$N and during postnatal period for VIA. (A) Plane of sections for analysis of 1H-
positive neurons in brain of E 12.5 embryos. (B-G) Equivalent rostral-to-caudal
sections through the midbrain of E12.5 wild-type (B,D,F) and ak (C,E,G) embryos
immunostained for 1H. (H,I) Coronal midbrain sections containing the SN and VIA
5$
in Pi wild-type (H) and ak (I) mice immunostained for TH. (J) $tereological
analysis of 1H-positive celis of the left SN and VIA in Pi wild-type and ak mice.
The data are represented as the mean±s.e.m. (n = 4). (K) Stereological analysis of
TH-positive celis of the lefi SN and VTA in P21 wild-type and ak mice (n = 4). A
statistically significant decrease in 1H-positive celi bodies was detected in the SN of
PI and P21 ak mice compared to controls (P<0.01, t-test) with no difference in the
VTA. (L) frequency of apoptotic celis revealed by TUNEL assay in the lefi SNc of
Pi wild-type and ak mice (n = 4). A statistically significant increase in the frequency
of apoptotic ceils was detected in the SNc of Pi ak mice compared to controls
(P<0.05, t-test).
Fig. 3. The ak mice have deficient striatal dopaminergic innervation. (A,B) Coronal
sections through the left striatum of P100 wild-type (A) and ak (B) mice
imrnunostained for 1H. Rostrocaudal positions are indicated as millimeters relative
to bregma in the lower right corner. Scale bar: 250 im. (C,D) DA concentration in
dorsal (C) and ventral (D) striatum of P130 wild-type and ak mice. Ihe data are
represented as the mean±s.e.m. (n = 4). A statistically significant decrease in DA
concentration was detected in the dorsal and ventral striatum of ak mice compared to
controls (P<0.01, t-test).
Fig. 4. The ak mice have impaired spontaneous locomotor activity. (A)
Spontaneous ambulatory activity of mice recorded over 23h. The distance (cm)
covered during each 1h period is shown for wild-type and ak mice. (B) Average
distance covered per hour for wild-type and ak mice during daytime and night-time.
(C) Average ambulatory time spent per hour for the recordings shown in A during
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daytime and night-time. (D) Spontaneous stereotypic movements of mice recorded
over 23 h. The stereotypic movements during each 1h period are shown for wild
type and ak mice. (E) Average numbers of stereotypic movements per hour for wild
type and ak mice during daytime and night-time. (F) Average time spent making
stereotypic movements per hour for the recordings shown in (D) during daytime and
night-time. (G) Resting time of mice recorded over 23h. The resting time during
each 1h period is shown for wild-type and ak mice. (H) Average resting time per
hour for wild-type and ak mice during daytime and night-time. (I) Average speed of
spontaneous ambulatory movements for wild-type and ak mice during daytime and
night-time. Ail locomotor activity data are represented as the mean±s.e.m. (n = 5).
Locomotor activity scores for ak mice that are significantly different from wild-type
scores are marked with a asterisk (P<O.O1, t-test).
Fig. 5. Similar distribution of MesDA neuronal losses in ak mice and in individuals
with Parkinson’s disease (PD). (A) The right midbrain of a normal mouse showing
the distribution of TH-positive Pitx3-positive (green with red core) and 1H-positive
Pitx3-negative (green) neurons in SNc and VTA. Most ventral $Nc TH-positive
neurons are Pitx3-positive, whereas the dorsal SNc largely contains Pitx3-negative
TH-positive neurons. About halfofthe VTA 1H-positive neurons are Pitx3-positive,
and both populations are intermingled. (B) In ak mice, SNc Pitx3-positive neurons
are lost between E12.5 and Pi, whereas VTA cells are lost postnatally. (C) Outline
of the right MesDA system of a normal human showing the distribution of TH
positive neurons in SNc and VIA. (D) Individuals with PD typically have the most
severe ceil depletion in ventral SNc, followed by dorsal SNc and VTA tmodified,
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with permission, from Jellinger (Jellinger 2001)]. Although a decrease of PITX3-
positive neurons was shown in samples from individuals with PD (Smidt et al.,
1997), the regional distribution of human PITX3-positive neurons remains to be
established.
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III. DISCUSSION AND PERSPECTIVES
The experimental data presented in this mémoire shed a new light on Fitx3
expression in the MesDA system and the in vivo role of the protein in this highly
complex midbrain structure. Until today, Pitx3 was believed to be expressed
throughout the MesDA system and to fulfili a hitherto unknown function in ail
MesDA neurons. We now show that in aduit mice, Fitx3 is expressed in most 1H-
positive neurons in the ventral tier of the SNc and about half of the TH-positive
neurons in the VIA, whereas the dorsal tier of the $Nc contains largely Pitx3-
negative TH-positive neurons. Pitx3 is therefore, together with Calbindin D2SK, the
only protein thus far known to specifically mark a discrete and identifiable region
within the SNc. Even more interestingiy, whereas Calbindin D2XK specifically marks
the dorsal tier of the $Nc, i.e. the nigral compartment least affected by PD, our
resuits indicate that Pitx3 is specifically expressed in the ventral tier of the SNc, i.e.
the nigral compartment most affected by this disease. Fitx3 is the first gene
identified having specific expression in those SNc neurons that are most vulnerable
for the PD process. It remains to be determined if these conclusions can be
extrapolated to the human situation, but since the mouse midbrain architecture is
highly similar to that in humans, there is reason to believe that Fitx3 might be a
unique marker for these $Nc neurons throughout mammalian species. In the VIA,
Pitx3-positive and Pitx3-negative celis appear to be intermingled, with no discrete
anatomical distribution. Even here though, the gene might mark those neurons that
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are lost in human PD, since VIA celi losses in PD have no discrete distribution
neither [8].
The analysis of the ak mouse mutant revealed that it is in fact a severe
hypomorphic or even nuil allele for Pitx3 at the brain level. Rieger et al. performed
quantitative real-time polymerase chain reaction (RT-PCR) of Fitx3 with total RNA
ftom heads of ak mutant and wildtype embryos and newboms and measured residual
expression of approximately 5% in mutants compared to wildtype [118]. We found
no Pitx3-immunoreactive celis in the MesDA system ofPlOO ak mice. The antibody
against Pitx3 we used during our experiments was raised against amino acids 9-45 of
rat Pitx3 [88], i.e. against amino acids encoded by DNA sequences that are
unaffected by the double-deletion mutation in the Fitx3 gene in ak mutant mice.
Thus, at the brain level of P100 ak mice, the Ïow level of Pitx3 transcripts does flot
seem to get translated in functional protein; a situation that can be well explained by
the fact that intron 1 cannot be spliced out of the aberrantly formed transcript due to
ffie deleted 5’ spiice site. P100 ak mice are thus very likely a nuil allele for Fitx3 at
the brain level. Pitx3-immunohistochemistry throughout embryogenesis and early
postnatal life needs to determine whether the ak mutation is also a nuil allele for
Pitx3 at younger developmental ages, but the RT-PCR data from Rieger et al.
strongly suggests this [118].
Our systematic analysis of serial midbrain sections in ak and wildtype P100
mice revealed that Pitx3-deficiency results in a severe depletion ofMesDA neurons.
This depletion affects the different compartments ofthe MesDA sytem in a different
way and follows the expression pattem of Fitx3; the ventral tier ofthe $Nc is almost
completely depleted of TH-positive neurons, the VIA lacks about haif of its 1H-
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positive fleurons, whereas the TH-positive neurons in the dorsal tier of the SNc are
largely preserved. The early development of the MesDA does not seem to be
affected in ak mice, but the $N neurons disappear dunng the fetal period and the
VTA neurons during the first postnatal months. Jncreased apoptosis seems to
contribute to this cell loss. Thus, Pitx3 does not only mark those MesDA neurons
that are most vulnerable for the PD process, it is also required for their survival. The
observation that the decrease in TH-positive cells in the SN is 91% at P1, 82% at
P21 and 71% at P100 probably finds its explanation in the phenomenon of
‘phenotypic maturation’ of MesDA neurons that extends into young adulthood. A
substantial part of the MesDA neurons, which are all generated on days E 10-E 14,
will not express TH until the first postnatal weeks and the proportion of ‘TH
immunostainable’ neurons relative to the total number of neurons present increases
over time and parallels the increase in TH neuron numbers in the SNc and VTA in
the first postnatal weeks [22]. The relative ‘increase’ of the number of TH-positive
cells in the SN of ak mice suggests that those SN neurons that ‘phenotypically
mature’ during fetal life are more affected by the Pitx3 deficienty than those that
‘phenotypically mature’ later, during the first postnatal weeks. Together with the
anatomical distribution of these affected celis, one might speculate that the MesDA
neurons that are most vulnerable for PD-related degeneration are those that
‘phenotypically mature’ during early MesDA development and that are Pitx3-
positive. In the VTA of ak mice, TH-positive celi numbers are not different at Pi,
tend to be lower at P21 and are reduced by 52% at P100, indicating that these VTA
neurons are lost later than the affected SN neurons. This may suggest that, although
this subpopulation of VTA neurons requires Pitx3 for their longterm survival, they
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are relatively more resistant to Pitx3-deficiency than their SN counterparts.
Altematively, VTA TH-positive neurons that ‘phenotypically mature’ during fetal
life could be less affected by the Pitx3 deficiency than those that ‘phenotypically
mature’ later, during the first postnatal weeks. One way or another, Pitx3 deficiency
clearly does flot affect the SN and VIA in the same way, underlining the different
properties ofthese neuronal populations.
The consequences of the ak midbrain phenotype are dramatic; DA levels are
reduced by 93% in the dorsal striatum, by 69% in the ventral striatum and the ak
mice have severe locomotor deficits. The preferential DA depletion in the dorsal
striatum correlates well with the preferential loss of ventral tier SNc fleurons, which
project to this brain structure. The DA depletion resuits in a marked reduction in
spontaneous ambulatory and stereotypic activities and ak mice are therefore severely
akinetic. Again, both these characteristics of ak mice are very similar to the
pathogenesis of human PD [131, 211]. From ifie observation that the speed of
spontaneous ambulatory movements was flot reduced in ak mice, one could
conclude that ak mice are not bradykinetic, an important characteristic of PD t121].
However, during our studies we only measured spontaneous movements and it
remains to be determined whether ak mice reach normal ambulatory speed when
they are forced to run or undergo a rotarod test. Besides, bradykinesia is defined as
both slowing of and difficulty in initiating movements and the observation that ak
mice spent significantly less time walldng and less time making stereotypic
movements may indicate a difficulty in initiating movements. It remains to be
determined whether the DA depletion in the ventral striatum, which correlates well
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with the loss of VIA neurons, modulates the emotionai behaviour of ak mice and
whether this influences the observed iocomotor deficits.
The ak mice thus recapitulate cardinal features of PD, in particular the
akinetic subtype of PD [211]. They therefore provide a usefiul animal model of PD;
MesDA neuronal losses in ak mice exceed 50% and can be readily detected using
biochemistry and neuropathoiogy, the mice have easiiy detectable akinesia and the
model is based on a single mutation to aliow robust propagation of the mutation as
weii as crossing with enhancer or suppressor strains. However, flot ail characteristics
of an ideal model of this disease have yet been investigated in ak mice. Besides, not
ail of them may be met. First, although MesDA neuronal losses in ak mice exceed
50%, the mice are aiready bom with a severely affected complement of MesDA
neurons and it remains to be determined whether there is progressive loss of these
neurons throughout aduit life, as in human PD. On the other hand, the ak disease
process seems short and would allow rapid screening of neuroprotective agents
during the fetal period (SNc) and the the first postnatal months (VIA). Second, it
remains to be determined whether Lewy bodies develop in ak mice. Third, aithough
ak mice are akinetic, other cardinal symptoms of PD, as rigidity and resting tremor,
are stili to be measured. No obvious rigidity and tremor were noted during routine
handiing of the ak mice, but previous experience with pharmacological depietion of
DA or DA-receptor antagonist suggests that mice do not develop these symptoms
[184]. fourth, it remains to be determined what postsynaptic effects the ak midbrain
phenotype with associated severe depletion of dorsal striatal DA levels has on the
development and function of striatal DA receptors, and whether the ak aldnetic
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motor deficit is responsive to treatment with DA receptor agonists. Taken together,
it is too preliminary to state that the ak mouse mutant is an ideal animal model of
PD, recapitulating ail of the key clinical and neuropathological features of PD. It is
the first known animal model, however, that accurately copies the stereotypic pattem
of $Nc ceil loss as seen in the human disease. Therefore, ak mice provide a very
useful animal model, not only to test therapies (drugs, gene or gene ffierapy) for PD,
but also to define a molecular mechanism explaining the selective sensitivity of
Pitx3 -expressing MesDA neurons to degeneration.
Indeed, the requirement of the homeobox transcription factor Pitx3 for
survival of Pitx3-expressing MesDA neurons suggests that Pitx3-dependent
functions may relate to the pathogenesis ofhuman PD. Such function or dowustream
target genes, thus far unidentified, may contribute to control of celi survivalldeath in
development andlor in pathogenesis of the MesDA system. Thus, Fitx3 gene
mutations may be involved in the etiology of diseases that affect the MesDA system.
Thus far, two mutations in the coding sequence of this gene have been identified in
families with ADCC and ASMD [111], diseases that show similarities with the
ocular phenotype of ak mice. Locomotor performance has flot been reported in these
heterozygous patients and it is noteworthy that both PITX3 mutations identified did
flot affect the homeodomain but rather amino acids in the flanking sequences that
have been proposed to participate in protein:protein interactions. It is possible that
the residues mutated in these alleles do not exert their dominant effect in MesDA
neurons as they appear to do for lens development. Thus, it would be worthwhile to
determine whether PITX3 alleles or mutated downstream target genes may
predispose to PD.
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Because of the implications in neurological and mental disorders, DA
belongs to the most intensively studied neurotransmitters of the brain and DA
systems have been the main target of neuropharmacology for more than 40 years.
The dramatic neurological consequences of degeneration of MesDA neurons in PD
highuight the functions of this DA system in the control of motor behavior at the
level of the striatum. The experimental data presented in this mémoire identify the
murine homeobox transcription factor Pitx3 as crucial for the survival of a highly
specific subset of MesDA fleurons, which shows close resemblance to the MesDA
neurons most vuinerable in PD. The Pitx3 gene therefore exerts an essential role in
the regulation of movement control. Interestingly, expression of the second member
of the Fitx gene family, Pitx2, is at the brain level confined to discrete nuclei of the
basal ganglia like the STN and the zona incerta pars dorsalis of the thalamus [104,
106]. The STN excites the output nuclei in the basal ganglia, the GPi and SNr, by
the means of the neurotransmitter glutamate [132]. In PD, reduced inhibtion of the
STN by the “indirect” GABAergic connection from the striatum, due to the DA
depletion in the dorsal striatum, causes increased output of the basal ganglia that
excessively inhibits the thalamic and brainstem nuclei, resulting in resting tremor,
rigidity and bradykinesia/aldnesia [127]. The STN thus plays an essentiai role in the
downstream effects of the midbrain pathology in PD, and inhibition of STN
excitation by bilateral deep-brain stimulation has striking benefits in terms of ail
aspects ofparkinsonism [212]. However, the STN does not only operate downstream
of MesDA fleurons. It is clearly established that STN glutamatergic neurons
influence both dopaminergic and non-dopaminergic neurons in the SN [134, 213],
and increases in glutamate may induce inhibition and degeneration of SN neurons
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[214, 215]. Recent studies in neurotoxin-induced animal models of PD show that
STN inhibition increases striatal dopamine levels and exerts neuroprotective effects
on SN DA neurons [216, 217]. The STN thus clearly influences $N function. Since
the role and clinical relevance of the STN are gradually elucidated and seem crucial
to both proper midbrain and basal ganglia physiology, it is important to understand
the development of this brain nucleus. The characteristic brain expression of the
Pitx2 gene herein is remarkable and the crucial role ofPitx3 in the development of
MesDA neurons, stresses the need for further research on the role of the Fitx2 gene
in the STN. Pitxl is, beside the pituitary gland, not expressed at the brain level. The
other two members of the Pitx gene family, however, might both be crucial in the
genetic pathways controlling midbrain and basal ganglia development.
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